{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:44Z","timestamp":1782722744348,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xkme.2026.101401","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:37:34Z","timestamp":1778765854000},"page":"101401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Fabry Disease Combined With Idiopathic Multicentric Castleman Disease and Membranous Nephropathy"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4846-7634","authenticated-orcid":false,"given":"Machiko","family":"Oka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikio","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.xkme.2026.101401_bib1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jmg.2008.065904","article-title":"Natural course of Fabry disease: changing pattern of causes of death in FOS\u2014Fabry Outcome Survey","volume":"46","author":"Mehta","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.xkme.2026.101401_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13023-015-0253-6","article-title":"Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document","volume":"10","author":"Biegstraaten","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.xkme.2026.101401_bib4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1182\/hematology.2024000582","article-title":"Identifying Castleman disease from non-clonal inflammatory causes of generalized lymphadenopathy","volume":"2024","author":"Nijim","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"16","key":"10.1016\/j.xkme.2026.101401_bib5","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman disease","volume":"135","author":"Dispenzieri","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.xkme.2026.101401_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jmg-2022-108523","article-title":"Prevalence of Fabry disease-causing variants in the UK Biobank","volume":"60","author":"Gilchrist","year":"2023","journal-title":"J Med Genet"},{"issue":"22","key":"10.1016\/j.xkme.2026.101401_bib7","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2018-05-848671","article-title":"Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease","volume":"132","author":"Fajgenbaum","year":"2018","journal-title":"Blood"},{"issue":"suppl 3","key":"10.1016\/j.xkme.2026.101401_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10545-007-0740-6","article-title":"Clinical manifestations and natural history of Japanese heterozygous females with Fabry disease","volume":"31","author":"Kobayashi","year":"2008","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.xkme.2026.101401_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12882-017-0472-2","article-title":"A rare case of renal thrombotic microangiopathy associated with Castleman\u2019s disease","volume":"18","author":"Mutneja","year":"2017","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101401_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-80633-6","article-title":"Glycosphingolipids and their impact on platelet activity in a murine model of Fabry disease","volume":"14","author":"Kanack","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xkme.2026.101401_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2013.02.003","article-title":"Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide","volume":"109","author":"De Francesco","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.xkme.2026.101401_bib12","article-title":"Systemic inflammation in Fabry disease: a longitudinal immuno-genetic analysis based on variant stratification","volume":"6","author":"Mar\u00edn G\u00f3mez","year":"2025","journal-title":"Ther Adv Rare Dis"},{"issue":"5","key":"10.1016\/j.xkme.2026.101401_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.nefroe.2025.04.010","article-title":"Fabry disease as a trigger of immune-mediated glomerular disease: Clinical hypotheses and literature review","volume":"45","author":"de Victoria Carazo","year":"2025","journal-title":"Nefrologia (Engl Ed)"},{"issue":"1","key":"10.1016\/j.xkme.2026.101401_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13023-017-0701-6","article-title":"Fabry disease and incidence of cancer","volume":"12","author":"Bird","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.xkme.2026.101401_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/2399369319852117","article-title":"Tumour incidence in Fabry disease: A cross-sectional study","volume":"3","author":"Rossi","year":"2019","journal-title":"J Onco-Nephrol"},{"key":"10.1016\/j.xkme.2026.101401_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2407-9-67","article-title":"Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis","volume":"9","author":"Johansson","year":"2009","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.xkme.2026.101401_bib17","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1158\/1535-7163.MCT-08-0430","article-title":"Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool","volume":"7","author":"Falgui\u00e8res","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"10.1016\/j.xkme.2026.101401_bib18","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.xkme.2026.101401_bib19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/nep.12977","article-title":"Globotriaosylsphingosine induces oxidative DNA damage in cultured kidney cells","volume":"22","author":"Biancini","year":"2017","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"10.1016\/j.xkme.2026.101401_bib20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jimd.12727","article-title":"Mass cytometry reveals atypical immune profile notably impaired maturation of memory CD4 T with Gb3-related CD27 expression in CD4 T cells in Fabry disease","volume":"47","author":"Mauhin","year":"2024","journal-title":"J Inherit Metab Dis"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526001639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526001639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:08:40Z","timestamp":1782720520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526001639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2590059526001639"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101401","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Rare Case of Fabry Disease Combined With Idiopathic Multicentric Castleman Disease and Membranous Nephropathy","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101401","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101401"}}